Exact Mass: 753.6482191999999
Exact Mass Matches: 753.6482191999999
Found 315 metabolites which its exact mass value is equals to given mass value 753.6482191999999
,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
PC(P-18:1(11Z)/P-18:1(11Z))
C44H84NO6P (753.6035933999999)
PC(P-18:1(11Z)/P-18:1(11Z)) is a phosphatidylcholine (PC or GPCho). It is a glycerophospholipid in which a phosphorylcholine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphocholines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PC(P-18:1(11Z)/P-18:1(11Z)), in particular, consists of two chains of plasmalogen 18:1n7 at the C-1 and C-2 positions. The plasmalogen 18:1n7 moieties are derived from animal fats, liver and kidney. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling.
PC(P-18:1(11Z)/P-18:1(9Z))
C44H84NO6P (753.6035933999999)
PC(P-18:1(11Z)/P-18:1(9Z)) is a phosphatidylcholine (PC or GPCho). It is a glycerophospholipid in which a phosphorylcholine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphocholines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PC(P-18:1(11Z)/P-18:1(9Z)), in particular, consists of one chain of plasmalogen 18:1n7 at the C-1 position and one chain of plasmalogen 18:1n9 at the C-2 position. The plasmalogen 18:1n7 moiety is derived from animal fats, liver and kidney, while the plasmalogen 18:1n9 moiety is derived from animal fats, liver and kidney. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling.
PC(P-18:1(9Z)/P-18:1(11Z))
C44H84NO6P (753.6035933999999)
PC(P-18:1(9Z)/P-18:1(11Z)) is a phosphatidylcholine (PC or GPCho). It is a glycerophospholipid in which a phosphorylcholine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphocholines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PC(P-18:1(9Z)/P-18:1(11Z)), in particular, consists of one chain of plasmalogen 18:1n9 at the C-1 position and one chain of plasmalogen 18:1n7 at the C-2 position. The plasmalogen 18:1n9 moiety is derived from animal fats, liver and kidney, while the plasmalogen 18:1n7 moiety is derived from animal fats, liver and kidney. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling.
PC(P-18:1(9Z)/P-18:1(9Z))
C44H84NO6P (753.6035933999999)
PC(P-18:1(9Z)/P-18:1(9Z)) is a phosphatidylcholine (PC or GPCho). It is a glycerophospholipid in which a phosphorylcholine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphocholines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PC(P-18:1(9Z)/P-18:1(9Z)), in particular, consists of two chains of plasmalogen 18:1n9 at the C-1 and C-2 positions. The plasmalogen 18:1n9 moieties are derived from animal fats, liver and kidney. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling.
1-O-(beta-D-glucopyranosyl)-(2S,3R,4E)-2-[(2R,13Z)-2-hydroxy-13-docosenoylamino]-1,3-dihydroxy-4-hexadecene
1,3,5,6-tetrahydroxy-2-(2-hydroxyoctadecanoylamino)-9-(E)-octacosene|lonijaposide A4
TG(14:0/16:1/14:0) (d5)
C47H83D5O6 (753.6894406900001)
1-hexadecanyl-2-(8-[3]-ladderane-octanyl)-sn-glycerophosphocholine
C44H84NO6P (753.6035933999999)
PC dO-36:4
C44H84NO6P (753.6035933999999)
N-[(2S,3R,4E,14Z)-1-(beta-D-glucopyranosyloxy)-3-hydroxyoctadeca-4,14-dien-2-yl]icosanamide
N-[(2S,3R,4E,14Z)-1-(beta-D-galactopyranosyloxy)-3-hydroxyoctadeca-4,14-dien-2-yl]icosanamide
(9Z,12Z,15Z,18Z,21Z,24Z,27Z,30Z,33Z)-N-[(4E,8E,12E)-1,3-dihydroxypentadeca-4,8,12-trien-2-yl]hexatriaconta-9,12,15,18,21,24,27,30,33-nonaenamide
(9Z,12Z,15Z,18Z,21Z,24Z,27Z,30Z,33Z,36Z,39Z)-N-[(E)-1,3-dihydroxynon-4-en-2-yl]dotetraconta-9,12,15,18,21,24,27,30,33,36,39-undecaenamide
(7Z,10Z,13Z,16Z,19Z,22Z,25Z,28Z,31Z)-N-[(4E,8E,12E)-1,3-dihydroxyheptadeca-4,8,12-trien-2-yl]tetratriaconta-7,10,13,16,19,22,25,28,31-nonaenamide
2-[2-[(Z)-hexacos-15-enoyl]oxy-3-octanoyloxypropoxy]-2-[2-(trimethylazaniumyl)ethoxy]acetate
(5Z,8Z,11Z,14Z,17Z,20Z,23Z,26Z,29Z)-N-[(4E,8E,12E)-1,3-dihydroxynonadeca-4,8,12-trien-2-yl]dotriaconta-5,8,11,14,17,20,23,26,29-nonaenamide
(6Z,9Z,12Z,15Z,18Z,21Z,24Z,27Z,30Z,33Z,36Z,39Z)-N-(1,3-dihydroxynonan-2-yl)dotetraconta-6,9,12,15,18,21,24,27,30,33,36,39-dodecaenamide
2-[2-[(Z)-nonadec-9-enoyl]oxy-3-pentadecanoyloxypropoxy]-2-[2-(trimethylazaniumyl)ethoxy]acetate
2-[3-icosanoyloxy-2-[(Z)-tetradec-9-enoyl]oxypropoxy]-2-[2-(trimethylazaniumyl)ethoxy]acetate
2-[2-[(Z)-docos-13-enoyl]oxy-3-dodecanoyloxypropoxy]-2-[2-(trimethylazaniumyl)ethoxy]acetate
2-[3-heptadecanoyloxy-2-[(Z)-heptadec-9-enoyl]oxypropoxy]-2-[2-(trimethylazaniumyl)ethoxy]acetate
2-[3-decanoyloxy-2-[(Z)-tetracos-13-enoyl]oxypropoxy]-2-[2-(trimethylazaniumyl)ethoxy]acetate
2-[3-henicosanoyloxy-2-[(Z)-tridec-9-enoyl]oxypropoxy]-2-[2-(trimethylazaniumyl)ethoxy]acetate
2-[3-hexadecanoyloxy-2-[(Z)-octadec-9-enoyl]oxypropoxy]-2-[2-(trimethylazaniumyl)ethoxy]acetate
2-[3-nonadecanoyloxy-2-[(Z)-pentadec-9-enoyl]oxypropoxy]-2-[2-(trimethylazaniumyl)ethoxy]acetate
2-[2-[(Z)-hexadec-9-enoyl]oxy-3-octadecanoyloxypropoxy]-2-[2-(trimethylazaniumyl)ethoxy]acetate
2-[2-[(Z)-icos-11-enoyl]oxy-3-tetradecanoyloxypropoxy]-2-[2-(trimethylazaniumyl)ethoxy]acetate
2-[2-[(Z)-henicos-11-enoyl]oxy-3-tridecanoyloxypropoxy]-2-[2-(trimethylazaniumyl)ethoxy]acetate
(7Z,10Z,13Z,16Z,19Z,22Z,25Z,28Z,31Z,34Z,37Z)-N-[(E)-1,3-dihydroxyundec-4-en-2-yl]tetraconta-7,10,13,16,19,22,25,28,31,34,37-undecaenamide
(8Z,11Z,14Z,17Z,20Z,23Z,26Z,29Z,32Z,35Z)-N-[(4E,8E)-1,3-dihydroxytrideca-4,8-dien-2-yl]octatriaconta-8,11,14,17,20,23,26,29,32,35-decaenamide
(6Z,9Z,12Z,15Z,18Z,21Z,24Z,27Z,30Z,33Z)-N-[(4E,8E)-1,3-dihydroxypentadeca-4,8-dien-2-yl]hexatriaconta-6,9,12,15,18,21,24,27,30,33-decaenamide
(E)-2-[[(Z)-hexacos-15-enoyl]amino]-3-hydroxynonadec-4-ene-1-sulfonic acid
C45H87NO5S (753.6304611999999)
(E)-2-[[(Z)-docos-13-enoyl]amino]-3-hydroxytricos-4-ene-1-sulfonic acid
C45H87NO5S (753.6304611999999)
(4E,8E)-3-hydroxy-2-(tetracosanoylamino)henicosa-4,8-diene-1-sulfonic acid
C45H87NO5S (753.6304611999999)
3-hydroxy-2-[[(11Z,14Z)-icosa-11,14-dienoyl]amino]pentacosane-1-sulfonic acid
C45H87NO5S (753.6304611999999)
3-hydroxy-2-[[(9Z,12Z)-nonadeca-9,12-dienoyl]amino]hexacosane-1-sulfonic acid
C45H87NO5S (753.6304611999999)
2-[[(11Z,14Z)-henicosa-11,14-dienoyl]amino]-3-hydroxytetracosane-1-sulfonic acid
C45H87NO5S (753.6304611999999)
(4E,8E)-2-(hexacosanoylamino)-3-hydroxynonadeca-4,8-diene-1-sulfonic acid
C45H87NO5S (753.6304611999999)
2-[[(15Z,18Z)-hexacosa-15,18-dienoyl]amino]-3-hydroxynonadecane-1-sulfonic acid
C45H87NO5S (753.6304611999999)
(4E,8E)-2-(docosanoylamino)-3-hydroxytricosa-4,8-diene-1-sulfonic acid
C45H87NO5S (753.6304611999999)
(4E,8E)-2-(henicosanoylamino)-3-hydroxytetracosa-4,8-diene-1-sulfonic acid
C45H87NO5S (753.6304611999999)
2-[[(13Z,16Z)-docosa-13,16-dienoyl]amino]-3-hydroxytricosane-1-sulfonic acid
C45H87NO5S (753.6304611999999)
(4E,8E)-3-hydroxy-2-(tricosanoylamino)docosa-4,8-diene-1-sulfonic acid
C45H87NO5S (753.6304611999999)
(E)-3-hydroxy-2-[[(Z)-tetracos-13-enoyl]amino]henicos-4-ene-1-sulfonic acid
C45H87NO5S (753.6304611999999)
(4E,8E)-3-hydroxy-2-(pentacosanoylamino)icosa-4,8-diene-1-sulfonic acid
C45H87NO5S (753.6304611999999)
(4E,8E)-3-hydroxy-2-(nonadecanoylamino)hexacosa-4,8-diene-1-sulfonic acid
C45H87NO5S (753.6304611999999)
(4E,8E)-3-hydroxy-2-(icosanoylamino)pentacosa-4,8-diene-1-sulfonic acid
C45H87NO5S (753.6304611999999)
3-hydroxy-2-[[(13Z,16Z)-tetracosa-13,16-dienoyl]amino]henicosane-1-sulfonic acid
C45H87NO5S (753.6304611999999)
(E)-3-hydroxy-2-[[(Z)-icos-11-enoyl]amino]pentacos-4-ene-1-sulfonic acid
C45H87NO5S (753.6304611999999)
(E)-2-[[(Z)-henicos-11-enoyl]amino]-3-hydroxytetracos-4-ene-1-sulfonic acid
C45H87NO5S (753.6304611999999)
(E)-3-hydroxy-2-[[(Z)-nonadec-9-enoyl]amino]hexacos-4-ene-1-sulfonic acid
C45H87NO5S (753.6304611999999)
2-[4-[3-[(Z)-docos-13-enoyl]oxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]pentanoylamino]acetic acid
4-(2-Heptacosanoyloxy-3-octanoyloxypropoxy)-2-(trimethylazaniumyl)butanoate
4-(2-Hexacosanoyloxy-3-nonanoyloxypropoxy)-2-(trimethylazaniumyl)butanoate
4-(3-Heptadecanoyloxy-2-octadecanoyloxypropoxy)-2-(trimethylazaniumyl)butanoate
4-(3-Hexadecanoyloxy-2-nonadecanoyloxypropoxy)-2-(trimethylazaniumyl)butanoate
4-(2-Icosanoyloxy-3-pentadecanoyloxypropoxy)-2-(trimethylazaniumyl)butanoate
4-(2-Henicosanoyloxy-3-tetradecanoyloxypropoxy)-2-(trimethylazaniumyl)butanoate
4-(2-Docosanoyloxy-3-tridecanoyloxypropoxy)-2-(trimethylazaniumyl)butanoate
4-(3-Dodecanoyloxy-2-tricosanoyloxypropoxy)-2-(trimethylazaniumyl)butanoate
4-(2-Tetracosanoyloxy-3-undecanoyloxypropoxy)-2-(trimethylazaniumyl)butanoate
4-(3-Decanoyloxy-2-pentacosanoyloxypropoxy)-2-(trimethylazaniumyl)butanoate
(18Z,21Z)-N-[3-hydroxy-1-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxytetradecan-2-yl]tetracosa-18,21-dienamide
(Z)-N-[(E)-3-hydroxy-1-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyhexadec-4-en-2-yl]docos-11-enamide
(4Z,7Z)-N-[3-hydroxy-1-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxydocosan-2-yl]hexadeca-4,7-dienamide
(Z)-N-[(E)-3-hydroxy-1-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxypentacos-4-en-2-yl]tridec-8-enamide
(Z)-N-[(E)-3-hydroxy-1-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyhexacos-4-en-2-yl]dodec-5-enamide
(Z)-N-[(E)-3-hydroxy-1-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxypentadec-4-en-2-yl]tricos-11-enamide
(Z)-N-[(E)-3-hydroxy-1-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxytetradec-4-en-2-yl]tetracos-11-enamide
(10Z,12Z)-N-[3-hydroxy-1-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyicosan-2-yl]octadeca-10,12-dienamide
(Z)-N-[(E)-3-hydroxy-1-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyheptadec-4-en-2-yl]henicos-9-enamide
(Z)-N-[(E)-3-hydroxy-1-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxydocos-4-en-2-yl]hexadec-7-enamide
(14Z,16Z)-N-[3-hydroxy-1-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyhexadecan-2-yl]docosa-14,16-dienamide
(Z)-N-[(E)-3-hydroxy-1-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyicos-4-en-2-yl]octadec-11-enamide
4-(2-Decanoyloxy-3-pentacosanoyloxypropoxy)-2-(trimethylazaniumyl)butanoate
4-(3-Tetracosanoyloxy-2-undecanoyloxypropoxy)-2-(trimethylazaniumyl)butanoate
4-(2-Dodecanoyloxy-3-tricosanoyloxypropoxy)-2-(trimethylazaniumyl)butanoate
4-(3-Docosanoyloxy-2-tridecanoyloxypropoxy)-2-(trimethylazaniumyl)butanoate
4-(3-Henicosanoyloxy-2-tetradecanoyloxypropoxy)-2-(trimethylazaniumyl)butanoate
4-(3-Icosanoyloxy-2-pentadecanoyloxypropoxy)-2-(trimethylazaniumyl)butanoate
4-(2-Hexadecanoyloxy-3-nonadecanoyloxypropoxy)-2-(trimethylazaniumyl)butanoate
4-(2-Heptadecanoyloxy-3-octadecanoyloxypropoxy)-2-(trimethylazaniumyl)butanoate
(E)-N-[(E,2S,3R)-3-hydroxy-1-[(2S,5R,6S)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyhexadec-8-en-2-yl]docos-13-enamide
N-[(2S,3R,4E,8E)-3-hydroxy-1-[(2S,5R,6S)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxytetradeca-4,8-dien-2-yl]tetracosanamide
(E)-N-[(E,2S,3R)-3-hydroxy-1-[(2S,5R,6S)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyicos-8-en-2-yl]octadec-9-enamide
N-[(2S,3R,4E,8E)-3-hydroxy-1-[(2S,5R,6S)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoctadeca-4,8-dien-2-yl]icosanamide
(E)-N-[(E,2S,3R)-3-hydroxy-1-[(2R,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyhenicos-4-en-2-yl]heptadec-9-enamide
(E)-N-[(E,2S,3R)-3-hydroxy-1-[(2S,5R,6S)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxytetradec-8-en-2-yl]tetracos-15-enamide
N-[(2S,3R,4E,6E)-3-hydroxy-1-[(2S,5R,6S)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyhexadeca-4,6-dien-2-yl]docosanamide
(E)-N-[(E,2S,3R)-3-hydroxy-1-[(2R,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxydocos-4-en-2-yl]hexadec-9-enamide
N-[(2S,3R,4E,8E)-3-hydroxy-1-[(2S,5R,6S)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyheptadeca-4,8-dien-2-yl]henicosanamide
(E)-N-[(E,2S,3R)-3-hydroxy-1-[(2S,5R,6S)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoctadec-8-en-2-yl]icos-11-enamide
N-[(2S,3R,4E,8E)-3-hydroxy-1-[(2R,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxydocosa-4,8-dien-2-yl]hexadecanamide
(E)-N-[(E,2S,3R)-3-hydroxy-1-[(2S,5R,6S)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoctadec-4-en-2-yl]icos-11-enamide
N-[(2S,3R,4E,14E)-3-hydroxy-1-[(2S,5R,6S)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoctadeca-4,14-dien-2-yl]icosanamide
(E)-N-[(E,2S,3R)-3-hydroxy-1-[(2R,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyhenicos-8-en-2-yl]heptadec-9-enamide
(E)-N-[(E,2S,3R)-3-hydroxy-1-[(2R,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxydocos-8-en-2-yl]hexadec-9-enamide
N-[(2S,3R,4E,6E)-3-hydroxy-1-[(2S,5R,6S)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxypentadeca-4,6-dien-2-yl]tricosanamide
N-[(2S,3R,4E,8E)-3-hydroxy-1-[(2S,5R,6S)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxynonadeca-4,8-dien-2-yl]nonadecanamide
(E)-N-[(E,2S,3R)-3-hydroxy-1-[(2S,5R,6S)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyhexadec-4-en-2-yl]docos-13-enamide
N-[(2S,3R,4E,8E)-3-hydroxy-1-[(2S,5R,6S)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyhexadeca-4,8-dien-2-yl]docosanamide
N-[(2S,3R,4E,8E)-3-hydroxy-1-[(2S,5R,6S)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxypentadeca-4,8-dien-2-yl]tricosanamide
(E)-N-[(E,2S,3R)-3-hydroxy-1-[(2S,5R,6S)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxytetradec-4-en-2-yl]tetracos-15-enamide
N-[(2S,3R,4E,8E)-3-hydroxy-1-[(2R,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyhenicosa-4,8-dien-2-yl]heptadecanamide
N-[(2S,3R,4E,6E)-3-hydroxy-1-[(2S,5R,6S)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxytetradeca-4,6-dien-2-yl]tetracosanamide
N-[(2S,3R,4E,8E)-3-hydroxy-1-[(2S,5R,6S)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyicosa-4,8-dien-2-yl]octadecanamide
(9E,12E)-N-[(2S,3R)-3-hydroxy-1-[(2R,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyicosan-2-yl]octadeca-9,12-dienamide
(E)-N-[(E,2S,3R)-3-hydroxy-1-[(2S,5R,6S)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyicos-4-en-2-yl]octadec-9-enamide
beta-D-glucosyl-(1<->1)-N-icosanoyl-(4E,14Z)-sphingadienine
A beta-D-glucosylceramide obtained by formal condensation of the carboxy group of icosanoic acid with the amino group of beta-D-glucosyl-(1<->1)-(4E,14Z)-sphingadienine.
beta-D-galactosyl-(1<->1)-N-icosanoyl-(4E,14Z)-sphingadienine
A galactosylceramide obtained by formal condensation of the carboxy group of icosanoic acid with the amino group of beta-D-galactosyl-(1<->1)-(4E,14Z)-sphingadienine.
Hex1Cer(38:2)
Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved
Hex1Cer(39:1)
Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved